McKesson (MCK) Revenue & Revenue Breakdown
McKesson Revenue Highlights
Latest Revenue (Y)
$308.95B
Latest Revenue (Q)
$79.28B
Main Segment (Y)
U.S. Pharmaceutical Segment
Main Geography (Y)
International Segment
McKesson Revenue by Period
McKesson Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $308.95B | 11.65% |
| 2023-03-31 | $276.71B | 4.83% |
| 2022-03-31 | $263.97B | 10.80% |
| 2021-03-31 | $238.23B | 3.11% |
| 2020-03-31 | $231.05B | 7.81% |
| 2019-03-31 | $214.32B | 2.86% |
| 2018-03-31 | $208.36B | 4.95% |
| 2017-03-31 | $198.53B | 4.01% |
| 2016-03-31 | $190.88B | 6.61% |
| 2015-03-31 | $179.04B | 30.11% |
| 2014-03-31 | $137.61B | 12.38% |
| 2013-03-31 | $122.45B | -0.23% |
| 2012-03-31 | $122.73B | 9.50% |
| 2011-03-31 | $112.08B | 3.11% |
| 2010-03-31 | $108.70B | 1.94% |
| 2009-03-31 | $106.63B | 4.85% |
| 2008-03-31 | $101.70B | 9.39% |
| 2007-03-31 | $92.98B | 5.60% |
| 2006-03-31 | $88.05B | 9.36% |
| 2005-03-31 | $80.51B | 15.84% |
| 2004-03-31 | $69.51B | 21.68% |
| 2003-03-31 | $57.12B | 14.23% |
| 2002-03-31 | $50.01B | 19.03% |
| 2001-03-31 | $42.01B | 14.36% |
| 2000-03-31 | $36.73B | 20.91% |
| 1999-03-31 | $30.38B | 45.67% |
| 1998-03-31 | $20.86B | 61.85% |
| 1997-03-31 | $12.89B | -6.05% |
| 1996-03-31 | $13.72B | 4.00% |
| 1995-03-31 | $13.19B | - |
McKesson generated $308.95B in revenue during NA 2024, up 11.65% compared to the previous quarter, and up 144.15% compared to the same period a year ago.
McKesson Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $79.28B | 3.83% |
| 2024-03-31 | $76.36B | -5.62% |
| 2023-12-31 | $80.90B | 4.77% |
| 2023-09-30 | $77.22B | 3.67% |
| 2023-06-30 | $74.48B | 8.09% |
| 2023-03-31 | $68.91B | -2.24% |
| 2022-12-31 | $70.49B | 0.47% |
| 2022-09-30 | $70.16B | 4.47% |
| 2022-06-30 | $67.15B | 1.59% |
| 2022-03-31 | $66.10B | -3.66% |
| 2021-12-31 | $68.61B | 3.06% |
| 2021-09-30 | $66.58B | 6.23% |
| 2021-06-30 | $62.67B | 5.97% |
| 2021-03-31 | $59.14B | -5.52% |
| 2020-12-31 | $62.60B | 2.95% |
| 2020-09-30 | $60.81B | 9.21% |
| 2020-06-30 | $55.68B | -4.88% |
| 2020-03-31 | $58.53B | -1.08% |
| 2019-12-31 | $59.17B | 2.70% |
| 2019-09-30 | $57.62B | 3.39% |
| 2019-06-30 | $55.73B | 6.29% |
| 2019-03-31 | $52.43B | -6.72% |
| 2018-12-31 | $56.21B | 5.90% |
| 2018-09-30 | $53.08B | 0.89% |
| 2018-06-30 | $52.61B | 1.90% |
| 2018-03-31 | $51.63B | -3.71% |
| 2017-12-31 | $53.62B | 2.99% |
| 2017-09-30 | $52.06B | 1.98% |
| 2017-06-30 | $51.05B | 4.80% |
| 2017-03-31 | $48.71B | -2.83% |
| 2016-12-31 | $50.13B | 0.35% |
| 2016-09-30 | $49.96B | 0.45% |
| 2016-06-30 | $49.73B | 6.54% |
| 2016-03-31 | $46.68B | -2.55% |
| 2015-12-31 | $47.90B | -1.77% |
| 2015-09-30 | $48.76B | 2.56% |
| 2015-06-30 | $47.55B | 10.00% |
| 2015-03-31 | $43.22B | -8.04% |
| 2014-12-31 | $47.01B | 5.02% |
| 2014-09-30 | $44.76B | 1.59% |
| 2014-06-30 | $44.06B | 15.51% |
| 2014-03-31 | $38.14B | 11.18% |
| 2013-12-31 | $34.31B | 4.10% |
| 2013-09-30 | $32.95B | 2.32% |
| 2013-06-30 | $32.21B | 5.19% |
| 2013-03-31 | $30.62B | -1.82% |
| 2012-12-31 | $31.19B | 4.48% |
| 2012-09-30 | $29.85B | -3.08% |
| 2012-06-30 | $30.80B | -2.84% |
| 2012-03-31 | $31.70B | 2.79% |
| 2011-12-31 | $30.84B | 2.06% |
| 2011-09-30 | $30.22B | 0.79% |
| 2011-06-30 | $29.98B | 3.91% |
| 2011-03-31 | $28.85B | 2.15% |
| 2010-12-31 | $28.25B | 2.59% |
| 2010-09-30 | $27.53B | 0.31% |
| 2010-06-30 | $27.45B | 3.03% |
| 2010-03-31 | $26.64B | -5.76% |
| 2009-12-31 | $28.27B | 4.21% |
| 2009-09-30 | $27.13B | 1.77% |
| 2009-06-30 | $26.66B | 1.65% |
| 2009-03-31 | $26.22B | -3.34% |
| 2008-12-31 | $27.13B | 2.09% |
| 2008-09-30 | $26.57B | -0.49% |
| 2008-06-30 | $26.70B | 1.80% |
| 2008-03-31 | $26.23B | - |
McKesson generated $79.28B in revenue during Q1 2025, up 3.83% compared to the previous quarter, and up 115.05% compared to the same period a year ago.
McKesson Revenue Breakdown
McKesson Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| International Segment | $14.13B | $20.60B | $35.97B | - | - |
| U.S. Pharmaceutical Segment | $278.74B | $240.62B | $212.15B | $189.27B | - |
| Prescription Technology Solutions | $4.77B | $4.39B | - | - | - |
| Medical-Surgical Solutions Segment | $11.31B | $11.11B | $11.61B | $10.10B | - |
| Prescription Technology Solutions Segment | - | $4.39B | $3.86B | $2.89B | - |
| Other Segments | - | - | - | - | $12.02B |
| Medical-Surgical Solutions | - | - | - | - | $8.30B |
McKesson's latest annual revenue breakdown by segment (product or service), as of Mar 24: U.S. Pharmaceutical Segment (90.22%), International Segment (4.57%), Medical-Surgical Solutions Segment (3.66%), and Prescription Technology Solutions (1.54%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Segment | $3.55B | $3.64B | $3.48B | $3.47B | $3.36B | $4.45B | $6.24B | $6.55B | $8.53B | $9.46B | $9.11B | $9.25B | $8.60B | $9.27B | $9.54B | - | - | - | - | - |
| U.S. Pharmaceutical Segment | $68.79B | $73.02B | $69.77B | $67.16B | $61.68B | $61.93B | $60.06B | $56.95B | $53.68B | $55.04B | $53.41B | $50.02B | $47.04B | $49.49B | $48.07B | - | - | - | - | - |
| Prescription Technology Solutions | $1.18B | $1.21B | $1.14B | $1.24B | $1.12B | $1.02B | $1.07B | $1.03B | $932.00M | $881.00M | - | - | - | - | - | - | - | - | - | - |
| Medical-Surgical Solutions Segment | $2.84B | $3.03B | $2.83B | $2.61B | $2.69B | $2.99B | $2.84B | $2.59B | $2.87B | $3.08B | $3.12B | $2.53B | $2.71B | $3.05B | $2.53B | - | - | - | - | - |
| Prescription Technology Solutions Segment | - | $1.21B | $789.00M | $777.00M | $668.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Segments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.57B | $2.90B | $3.18B | $2.98B | $2.95B |
| Medical-Surgical Solutions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.80B | $2.21B | $2.14B | $2.06B | $1.90B |
| U.S. Pharmaceutical and Specialty Solutions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $45.06B | $46.27B | $46.92B | $45.98B | $44.16B |
McKesson's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: U.S. Pharmaceutical Segment (90.09%), International Segment (4.65%), Medical-Surgical Solutions Segment (3.72%), and Prescription Technology Solutions (1.55%).
McKesson Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 24 | Mar 23 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| International Segment | $14.13B | $20.60B | - | - | - |
| UNITED STATES | - | - | $192.71B | $176.30B | $169.94B |
| Non-US | - | - | $38.34B | $38.02B | $38.41B |
McKesson's latest annual revenue breakdown by geography, as of Mar 24: International Segment (100.00%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| International Segment | $3.55B | $3.64B | - | - | - | - | - | - | - | - | - |
| Non-US | - | - | $8.55B | $9.75B | $9.86B | $9.32B | $9.41B | $9.32B | $9.69B | $9.30B | $9.72B |
| UNITED STATES | - | - | $47.13B | $48.78B | $49.31B | $48.29B | $46.32B | $43.11B | $46.52B | $43.77B | $42.89B |
McKesson's latest quarterly revenue breakdown by geography, as of Mar 24: International Segment (100.00%).
McKesson Peer Comparison by Revenue
MCK Revenue FAQ
What is McKesson’s yearly revenue?
McKesson's yearly revenue for 2024 was $308.95B, representing an increase of 11.65% compared to 2023. The company's yearly revenue for 2023 was $276.71B, representing an increase of 4.83% compared to 2022. MCK's yearly revenue for 2022 was $263.97B, representing an increase of 10.80% compared to 2021.
What is McKesson’s quarterly revenue?
McKesson's quarterly revenue for Q1 2025 was $79.28B, a 3.83% increase from the previous quarter (Q4 2024), and a 6.44% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $76.36B, a -5.62% decrease from the previous quarter (Q3 2024), and a 10.80% increase year-over-year (Q4 2023). MCK's quarterly revenue for Q3 2024 was $80.9B, a 4.77% increase from the previous quarter (Q2 2024), and a 14.77% increase year-over-year (Q3 2023).
What is McKesson’s revenue growth rate?
McKesson's revenue growth rate for the last 3 years (2022-2024) was 17.04%, and for the last 5 years (2020-2024) was 33.72%.
What are McKesson’s revenue streams?
McKesson's revenue streams in r 24 are International Segment, U.S. Pharmaceutical Segment, Prescription Technology Solutions, and Medical-Surgical Solutions Segment. International Segment generated $14.13B in revenue, accounting 4.57% of the company's total revenue, down -31.40% year-over-year. U.S. Pharmaceutical Segment generated $278.74B in revenue, accounting 90.22% of the company's total revenue, up 15.84% year-over-year. Prescription Technology Solutions generated $4.77B in revenue, accounting 1.54% of the company's total revenue, up 8.71% year-over-year. Medical-Surgical Solutions Segment generated $11.31B in revenue, accounting 3.66% of the company's total revenue, up 1.83% year-over-year.
What is McKesson’s main source of revenue?
For the fiscal year ending Mar 24, the largest source of revenue of McKesson was U.S. Pharmaceutical Segment. This segment made a revenue of $278.74B, representing 90.22% of the company's total revenue.